生物恢复疗法胜于收入预测,但其股票价格跌至1.81美元。 BioRestorative Therapies beat earnings forecasts but saw its stock price fall to $1.81.

生物恢复疗法是一家再生医药公司,它报告的收入比分析家的预期的每股7美元少,50万美元的收入超过48万美元的预测。 BioRestorative Therapies, a regenerative medicine company, reported earnings that beat analysts' expectations by $0.07 per share, with revenue of $0.50 million exceeding forecasts of $0.48 million. 尽管取得了积极成果,但该公司的股票价格下跌了2美元,降至181美元,市场上限为1 253万美元。 Despite the positive results, the company's stock price fell $0.02 to $1.81, and it has a market cap of $12.53 million. 该公司的重点是开发治疗方法,利用成人干细胞治疗盘尾/脊髓灰质炎和代谢紊乱等疾病。 The company focuses on developing therapies using adult stem cells for conditions like disc/spine disease and metabolic disorders.